Ensure Biobank Growth with High Quality Samples, Effective Data Management, Knowledge Sharing and Compliance
Biobanks are acknowledged as a necessary and powerful resource for R&D with access to millions of samples and the associated data collected with them.
The level and consistency of sample quality can have a huge impact on the validity of research findings
. It is therefore critical for biobanks to ensure the high quality of their samples. With many large scale studies acquiring samples across multiple biobanks, it has become essential for both the standard of sample quality and the data collected to be harmonised.
The 13th Annual Global Biobanking Summit
will address the issues of quality and data standards as well as processes and technologies implemented to ensure traceability. Download the 2015 Agenda for more details.
Key Sessions from the 2015 event included:
- Explore the latest initiatives to harmonise sample quality and data standards with Anne Carter, UCL, and Georges Dagher, INSERM
- Develop best practice to obtain samples globally and track consent with Karina Bienfait, Merck
- Evaluate effective processses to ensure sample quality and integrity with Victoria Haggerson, GSK, and Cheryl Gillett, KCL
- Increase sample utilisation and create a collaborative public-private partnership with Francisco de Luna, CNIO, and John Spaull, GSK
“Excellent content - very valuable” National Cancer Institute
“Very nice presentations withspot on subjects. Very good sessions” Erasmus MC Tissue Bank
“In such a topically diverse area, IQPC delivered a top class agenda with speakers and delegates to match” Qiagen